304 related articles for article (PubMed ID: 25938542)
1. CDC20 maintains tumor initiating cells.
Xie Q; Wu Q; Mack SC; Yang K; Kim L; Hubert CG; Flavahan WA; Chu C; Bao S; Rich JN
Oncotarget; 2015 May; 6(15):13241-54. PubMed ID: 25938542
[TBL] [Abstract][Full Text] [Related]
2. A CDC20-APC/SOX2 Signaling Axis Regulates Human Glioblastoma Stem-like Cells.
Mao DD; Gujar AD; Mahlokozera T; Chen I; Pan Y; Luo J; Brost T; Thompson EA; Turski A; Leuthardt EC; Dunn GP; Chicoine MR; Rich KM; Dowling JL; Zipfel GJ; Dacey RG; Achilefu S; Tran DD; Yano H; Kim AH
Cell Rep; 2015 Jun; 11(11):1809-21. PubMed ID: 26074073
[TBL] [Abstract][Full Text] [Related]
3. ST3GAL1-Associated Transcriptomic Program in Glioblastoma Tumor Growth, Invasion, and Prognosis.
Chong YK; Sandanaraj E; Koh LW; Thangaveloo M; Tan MS; Koh GR; Toh TB; Lim GG; Holbrook JD; Kon OL; Nadarajah M; Ng I; Ng WH; Tan NS; Lim KL; Tang C; Ang BT
J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26547933
[TBL] [Abstract][Full Text] [Related]
4. FoxM1 Promotes Stemness and Radio-Resistance of Glioblastoma by Regulating the Master Stem Cell Regulator Sox2.
Lee Y; Kim KH; Kim DG; Cho HJ; Kim Y; Rheey J; Shin K; Seo YJ; Choi YS; Lee JI; Lee J; Joo KM; Nam DH
PLoS One; 2015; 10(10):e0137703. PubMed ID: 26444992
[TBL] [Abstract][Full Text] [Related]
5. APC/C(Cdc20) controls the ubiquitin-mediated degradation of p21 in prometaphase.
Amador V; Ge S; Santamaría PG; Guardavaccaro D; Pagano M
Mol Cell; 2007 Aug; 27(3):462-73. PubMed ID: 17679094
[TBL] [Abstract][Full Text] [Related]
6. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth.
Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S
Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911
[TBL] [Abstract][Full Text] [Related]
7. Driver or passenger effects of augmented c-Myc and Cdc20 in gliomagenesis.
Ji P; Zhou X; Liu Q; Fuller GN; Phillips LM; Zhang W
Oncotarget; 2016 Apr; 7(17):23521-9. PubMed ID: 26993778
[TBL] [Abstract][Full Text] [Related]
8. Cool-1-mediated inhibition of c-Cbl modulates multiple critical properties of glioblastomas, including the ability to generate tumors in vivo.
Stevens BM; Folts CJ; Cui W; Bardin AL; Walter K; Carson-Walter E; Vescovi A; Noble M
Stem Cells; 2014 May; 32(5):1124-35. PubMed ID: 24458840
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of mitochondrial NAD
Son MJ; Ryu JS; Kim JY; Kwon Y; Chung KS; Mun SJ; Cho YS
Exp Mol Med; 2017 Jun; 49(6):e344. PubMed ID: 28604662
[TBL] [Abstract][Full Text] [Related]
10. PKCδ maintains phenotypes of tumor initiating cells through cytokine-mediated autocrine loop with positive feedback.
Kim RK; Suh Y; Hwang E; Yoo KC; Choi KS; An S; Hwang SG; Kim IG; Kim MJ; Lee HJ; Lee SJ
Oncogene; 2015 Nov; 34(46):5749-59. PubMed ID: 25746003
[TBL] [Abstract][Full Text] [Related]
11. FoxM1B is overexpressed in human glioblastomas and critically regulates the tumorigenicity of glioma cells.
Liu M; Dai B; Kang SH; Ban K; Huang FJ; Lang FF; Aldape KD; Xie TX; Pelloski CE; Xie K; Sawaya R; Huang S
Cancer Res; 2006 Apr; 66(7):3593-602. PubMed ID: 16585184
[TBL] [Abstract][Full Text] [Related]
12. RBPJ maintains brain tumor-initiating cells through CDK9-mediated transcriptional elongation.
Xie Q; Wu Q; Kim L; Miller TE; Liau BB; Mack SC; Yang K; Factor DC; Fang X; Huang Z; Zhou W; Alazem K; Wang X; Bernstein BE; Bao S; Rich JN
J Clin Invest; 2016 Jul; 126(7):2757-72. PubMed ID: 27322055
[TBL] [Abstract][Full Text] [Related]
13. Chromosomal Instability Affects the Tumorigenicity of Glioblastoma Tumor-Initiating Cells.
Godek KM; Venere M; Wu Q; Mills KD; Hickey WF; Rich JN; Compton DA
Cancer Discov; 2016 May; 6(5):532-45. PubMed ID: 27001151
[TBL] [Abstract][Full Text] [Related]
14. Chromatin remodeler HELLS maintains glioma stem cells through E2F3 and MYC.
Zhang G; Dong Z; Prager BC; Kim LJ; Wu Q; Gimple RC; Wang X; Bao S; Hamerlik P; Rich JN
JCI Insight; 2019 Apr; 4(7):. PubMed ID: 30779712
[TBL] [Abstract][Full Text] [Related]
15. Inhibiting the anaphase promoting complex/cyclosome induces a metaphase arrest and cell death in multiple myeloma cells.
Lub S; Maes A; Maes K; De Veirman K; De Bruyne E; Menu E; Fostier K; Kassambara A; Moreaux J; Hose D; Leleu X; King RW; Vanderkerken K; Van Valckenborgh E
Oncotarget; 2016 Jan; 7(4):4062-76. PubMed ID: 26716651
[TBL] [Abstract][Full Text] [Related]
16. Scalable Culturing of Primary Human Glioblastoma Tumor-Initiating Cells with a Cell-Friendly Culture System.
Li Q; Lin H; Rauch J; Deleyrolle LP; Reynolds BA; Viljoen HJ; Zhang C; Zhang C; Gu L; Van Wyk E; Lei Y
Sci Rep; 2018 Feb; 8(1):3531. PubMed ID: 29476107
[TBL] [Abstract][Full Text] [Related]
17. MYC-Regulated Mevalonate Metabolism Maintains Brain Tumor-Initiating Cells.
Wang X; Huang Z; Wu Q; Prager BC; Mack SC; Yang K; Kim LJY; Gimple RC; Shi Y; Lai S; Xie Q; Miller TE; Hubert CG; Song A; Dong Z; Zhou W; Fang X; Zhu Z; Mahadev V; Bao S; Rich JN
Cancer Res; 2017 Sep; 77(18):4947-4960. PubMed ID: 28729418
[TBL] [Abstract][Full Text] [Related]
18. Chromatin regulator PRC2 is a key regulator of epigenetic plasticity in glioblastoma.
Natsume A; Ito M; Katsushima K; Ohka F; Hatanaka A; Shinjo K; Sato S; Takahashi S; Ishikawa Y; Takeuchi I; Shimogawa H; Uesugi M; Okano H; Kim SU; Wakabayashi T; Issa JP; Sekido Y; Kondo Y
Cancer Res; 2013 Jul; 73(14):4559-70. PubMed ID: 23720055
[TBL] [Abstract][Full Text] [Related]
19. The zinc finger transcription factor ZFX is required for maintaining the tumorigenic potential of glioblastoma stem cells.
Fang X; Huang Z; Zhou W; Wu Q; Sloan AE; Ouyang G; McLendon RE; Yu JS; Rich JN; Bao S
Stem Cells; 2014 Aug; 32(8):2033-47. PubMed ID: 24831540
[TBL] [Abstract][Full Text] [Related]
20. The mitotic kinesin KIF11 is a driver of invasion, proliferation, and self-renewal in glioblastoma.
Venere M; Horbinski C; Crish JF; Jin X; Vasanji A; Major J; Burrows AC; Chang C; Prokop J; Wu Q; Sims PA; Canoll P; Summers MK; Rosenfeld SS; Rich JN
Sci Transl Med; 2015 Sep; 7(304):304ra143. PubMed ID: 26355032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
